SCHEMBL17900855

SCHEMBL17900855

NS(=O)(=O)NCC1OC(n2cnc3c(N[C@@H](CO)c4ccccc4)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.59
ADORA2A P29274 3/20 0.59
ADORA2B P29275 2/20 0.59
ADORA1 P30542 2/20 0.59
TSHR P16473 2/20 0.55
NFKB1 P19838 2/20 0.55
ALDH1A1 P00352 2/20 0.55
PMP22 Q01453 2/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
RXFP1 Q9HBX9 2/20 0.55
TP53 P04637 1/20 0.55
CYP3A4 P08684 1/20 0.55
ALOX12 P18054 1/20 0.55
HIF1A Q16665 1/20 0.55
HPGD P15428 1/20 0.55
LMNA P02545 2/20 0.54
GLA P06280 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
NPY1R P25929 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12652308 1.00 ADORA3 (0.59) ADORA3ADORA2AADORA2BADORA1TSHR
SCHEMBL12652598 1.00 ADORA3 (0.59) ADORA3ADORA2AADORA2BADORA1TSHR
SCHEMBL1800313 1.00 ADORA3 (0.59) ADORA3ADORA2AADORA2BADORA1TSHR
SCHEMBL17900857 1.00 ADORA3 (0.59) ADORA3ADORA2AADORA2BADORA1TSHR
SCHEMBL1797094 1.00 ADORA3 (0.59) ADORA3ADORA2AADORA2BADORA1TSHR
SCHEMBL1798220 0.93 ADORA3 (0.59) ADORA3ADORA2AADORA2BADORA1TSHR
SCHEMBL1796587 0.93 ADORA3 (0.59) ADORA3ADORA2AADORA2BADORA1TSHR
SCHEMBL12652499 0.89 UBA6 (0.62) ADORA3ADORA2AADORA2BADORA1TSHR
SCHEMBL1796596 0.89 UBA6 (0.62) ADORA3ADORA2AADORA2BADORA1TSHR
SCHEMBL1798225 0.89 UBA6 (0.62) ADORA3ADORA2AADORA2BADORA1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160194348-A1 SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES MILLENNIUM PHARM INC (US) 2016-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160194348-A1 SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES TYMP, TYMS, PPA1 ADORA3 1669/4885ADORA2A 1750/4885ADORA2B 2252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.